For example, GENFIT and BICOLL identified the first potent bioavailable natural product neoruscogenin as a specific agonist of RORα, and they are developing neoruscogenin as a therapeutic drug for autoimmune disorders in the preclinical stage76. This evidence concerns the gene RORA and autoimmune disease.